Effects of artonin e on migration and invasion capabilities of human lung cancer cells

Kanok Plaibua1, Varisa Pongrakhananon, Preedakorn Chunhacha

  • 1Departments of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phatumwan, Bangkok, Thailand 10330. pithi_chan@yahoo.com

Anticancer Research
|July 31, 2013
PubMed
Abstract

Insights

Artonin E, a compound from Artocarpus gomezianus, effectively inhibits lung cancer cell migration and invasion. This natural compound shows promise for developing new anti-metastasis cancer therapies.

Area of Science:

  • Natural Product Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Substances that reduce cancer cell motility are crucial for developing novel anticancer strategies.
  • Artonin E is a compound extracted from the bark of Artocarpus gomezianus.
  • Its potential anti-migration and anti-invasion activities in lung cancer were unexplored.

Purpose of the Study:

  • To investigate the anti-migration and anti-invasion activities of artonin E in human lung cancer cells.
  • To explore the molecular mechanisms underlying artonin E's effect on cancer cell motility.
  • To evaluate artonin E as a potential therapeutic agent against lung cancer metastasis.

Main Methods:

  • Cytotoxicity and antiproliferative effects were assessed using the MTT assay.
  • Migration and invasion assays were conducted on H460, H23, A549, and H292 lung cancer cell lines.
  • Cell morphology was analyzed via phalloidin-rhodamine staining, and motility-related proteins were examined by western blotting.

Main Results:

  • Artonin E demonstrated significant anti-migration and anti-invasion effects in H460 lung cancer cells.
  • Non-toxic concentrations of artonin E reduced activated focal adhesion kinase (FAK), protein kinase B (AKT), and Cell division cycle-42 (CDC42) activation.
  • Artonin E also inhibited migration and invasion in H292, H23, and A549 lung cancer cell lines.

Conclusions:

  • Artonin E exhibits potent anti-metastasis properties against various human lung cancer cells.
  • The compound's mechanism involves the downregulation of key motility-related proteins.
  • Artonin E represents a promising candidate for the development of novel anti-metastasis therapies.